RANDY JOHNSON: Open Payments
NPI 1073787677 · HAMDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$910 in 38 payments from 13 companies in 2025. Trend: 2023 $910 · 2024 $639 · 2025 $910
Food & beverage: $910
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $275 |
| Ardelyx, Inc. | 6 | $131 |
| Madrigal Pharmaceuticals | 1 | $128 |
| Janssen Biotech, Inc. | 3 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $48 |
| Gilead Sciences, Inc. | 2 | $34 |
| QOL Medical, LLC | 1 | $34 |
| EVOKE PHARMA, INC. | 2 | $31 |
| Medline Industries LP | 1 | $29 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
Products named: IBSRELA, REZDIFFRA, TREMFYA, VIBERZI, RINVOQ, LINZESS, XIFAXAN, Sucraid.
Industry payments across CT — which companies pay providers there.
